Rotta J, Bednár B, Rýc M
J Hyg Epidemiol Microbiol Immunol. 1977;21(4):433-40.
Induced tolerance to the pyrogenic action of group A streptococcus peptidoglycan decreased after one week and was no longer detectable after the second week. However, one or two further doses of peptidoglycan rapidly restored the tolerance. The passive transfer of plasma from rabbits tolerant to streptococcus peptidoglycan to nontolerant animals failed to transfer tolerance. Antiserum to streptococcus peptidoglycan neutralized the pyrogenic effect of not only streptococcus but also staphylococcus and pneumococcus peptidoglycan; it did not influence the febrile response to endotoxin. Histopathologic changes in the rabbit heart produced by the intravenous injection of staphylococcus or pneumococcus peptidoglycans were similar and were characterized by various stages of degeneration and necrosis. The changes were less pronounced than after streptococcus peptidoglycan. Antiserum to streptococcus peptidoglycan had modest or no counteracting effect on the development of heart alterations after staphylococcus or pneumococcus peptidoglycan.
对A组链球菌肽聚糖致热作用的诱导耐受性在一周后降低,第二周后则不再能检测到。然而,再给予一到两剂肽聚糖可迅速恢复耐受性。将耐受链球菌肽聚糖的兔子的血浆被动转移至未耐受的动物未能传递耐受性。抗链球菌肽聚糖抗血清不仅中和了链球菌肽聚糖的致热作用,还中和了葡萄球菌和肺炎球菌肽聚糖的致热作用;它不影响对内毒素的发热反应。静脉注射葡萄球菌或肺炎球菌肽聚糖在兔心脏中产生的组织病理学变化相似,其特征为不同阶段的变性和坏死。这些变化比链球菌肽聚糖注射后要轻。抗链球菌肽聚糖抗血清对葡萄球菌或肺炎球菌肽聚糖注射后心脏病变的发展具有适度或无对抗作用。